Bioanalytical Testing Services Market

Key Highlights of the report

How are the major segments performing in the Bioanalytical Testing Services Market?

• The biomarker testing type segment dominated the global market in 2021 due to the high demand for these services in developing generic drugs. Additionally, the rising concern among consumers over self-care is driving up demand for pharmaceuticals.
• In 2021, the oncology application segment accounted for the majority of global market revenue, owing to the increasing number of oncology clinical trials and the global prevalence of cancer.
• In 2021, the pharmaceutical & biopharmaceutical companies end-user segment accounted for the major global market revenue share. The segment is expected to grow due to factors such as pharmaceutical companies’ improved outsourcing of early-phase clinical, development, and laboratory testing services to increase profit margins, avoid high capital expenditures, and shorten the process and product validation time.

What is the Market Size of Bioanalytical Testing Services regarding value?

The global bioanalytical testing services market is anticipated to grow at a substantial CAGR of 15.2% in the upcoming years. The global Bioanalytical Testing Services industry was estimated to be worth USD 2754.9 million in 2021 and was expected to be worth USD 6439.03 million by 2028.

Which region dominated the bioanalytical testing services market?

North America is expected to be the most appealing region globally for bioanalytical testing services during the projected period. The growing use of peptides and other large molecule therapeutic applications to serve a large patient population account for more than 45% of North America’s bioanalytical testing services market. The increase in pharmaceutical industries in countries such as the United States and Canada can also be attributed to the growth. Clinical trials are supported to increase the market for bioanalytical testing in the region due to benefits such as cost savings, participant retention, and improved regulatory procedures.

How is US Market Performing in the bioanalytical testing services market?

Due to the increasing demand for bioanalytical services with a high volume of ongoing research activities and clinical trials, the United States holds the largest market share in North America for bioanalytical testing services. The US has the largest market share in North America as there are more people with chronic diseases, and since peptides and other large molecules are increasingly used as therapeutics instead of small molecules, which have more side effects. As per the Centers for Disease Control and Prevention, chronic diseases cost the United States approximately USD 3.5 trillion. As a result, businesses have been taking action to meet the high demand, which is anticipated to drive the US market.

What is the competitive environment of the bioanalytical testing services market?

The main strategic initiatives of bioanalytical testing services market participants include alliances, service portfolio expansion, and mergers and acquisitions. The leading businesses are also strengthening their market positions by offering a range of services, validating assays, introducing new approaches for method development, and offering other laboratory solutions. For instance, Almac Sciences, a subsidiary of the Almac Group, announced the inclusion of biosimilar testing to its existing portfolio of analytical solutions in September 2020. This new service follows the company’s 2019 announcement of the expansion of its Ireland lab, from which Almac Sciences offers a wide range of flexible pharmacological testing services to assist clients’ drug development programs while abiding by industry regulations like the EMA, FDA, and PMDA under GMP standards.

Executive Summary

What are the key trends or recent developments in the Bioanalytical Testing Services Market?

• Charles River Laboratories announced in February 2021 that it had acquired Cognate BioServices, a leading contract development and manufacturing organization (CDMO) for cell and gene therapy, and Cobra Biologics, its division for gene therapy. As a result of the acquisition, Charles River will become a preeminent scientific partner for the development, testing, and manufacturing of cell and gene therapies, offering customers an integrated approach from initial research and discovery to CGMP production.
• SGS SA announced in February 2020 that its Center of Excellence for Biosafety laboratory would provide Good Manufacturing Practice (GMP)-compliant vaccine verification solutions for coronavirus, which is likely to aid in the detection of novel coronaviruses with effective testing solutions.

What are all the technical developments in the Bioanalytical Testing Services Market?

The ability to detect biomarkers more quickly, precisely, and sensitively in intricate biological samples is made possible by advancements in analytical technologies and instrumentation. Additionally, a growing emphasis on creating advanced bioanalytical technologies for enhanced testing is anticipated to support market expansion. The introduction of biologics, combination products, and other novel medicines has heightened the need for specific testing procedures. The majority of outsourcing CROs are implementing novel methods for quantifying PK parameters.

Which are the key investments by the bioanalytical testing services market players?

Most pharmaceutical companies, bioanalytical laboratories, and contract research organizations (CROs) are expanding their bioanalytical services and investing in bioanalytical testing laboratories. End users are promoting in-house tests and extending testing capabilities in various locations due to the increased demand for pharmaceutical products. The two main factors influencing investments in bioanalytical R&D and laboratories are the rise in demand for biopharma products and the need to develop novel bioanalytical assay platforms. For instance, SGS, a provider of contract solutions for biopharmaceutical analytical and bioanalytical testing, invested USD 3.95 million in two projects in December 2018 to increase its Poitiers, France, bioanalytical testing capabilities.

Some major players in the bioanalytical testing services market are PPD, Icon Plc, Covance Inc, LabCorp, Charles River Laboratories International Inc, Syneos Health, SGS SA, Toxikon Inc, Intertek Group, and Pace Analytical Services LLC.

What are the Major Driving Factors for the Bioanalytical Testing Services Market?

The rise in market demand for bioanalytical testing services has been attributed primarily to the global prevalence of chronic diseases like cancer and HIV. The increasing use of bioanalytical tests in clinical trials of biological markers, both large and small molecules, is another important factor driving the growth of the bioanalytical testing services market. Pharmaceutical product use has also increased due to rising consumer awareness, aggressive marketing campaigns, government initiatives, and improved accessibility. This has led to a rapid expansion of the market for bioanalytical testing and services. Furthermore, rising outbreaks of highly infectious diseases such as COVID-19 and government healthcare initiatives have created new opportunities for the bioanalytical testing services market to expand in the coming years.

What are the Major Risks for the Bioanalytical Testing Services Market?

A shortage of skilled professionals for research purposes, as well as a lack of infrastructure in several regions, may limit the growth of the bioanalytical testing services market. It is further anticipated that high costs for the provision of biomedical testing services will impede market expansion. In developing nations with inadequate healthcare infrastructure, where services for biomedical testing, which have no immediate advantages, are unavailable, this becomes very challenging to manage.

Which is the key end user in the bioanalytical testing services market?

Pharmaceutical and biopharmaceutical companies currently have the largest market share. They are expected to significantly increase their market share and monopolize the global bioanalytical testing services market in the coming years. Pharmaceutical firms are increasingly outsourcing early-stage development, clinical, and laboratory testing services to boost profit margins, avoid high capital expenditures, and shorten the time it takes to validate processes and services, which comprise a significant portion of this market. Most pharma companies, bioanalytical labs, and CROs are expanding their bioanalytical services and investing in bioanalytical testing labs.

How is the bioanalytical testing services market performing in regions?

In 2021, North America dominated the global bioanalytical testing services market. The market dominance of the region is primarily attributable to the presence of numerous significant players, the rising demand for bioanalytical services, the abundance of ongoing clinical trials and research, and the region’s highly developed and dependable healthcare infrastructure. For instance, SGS SA announced in February 2020 that the laboratory at its Centre of Excellence for Biosafety offers coronavirus vaccine testing services that comply with GMP. The bio-safety laboratory’s amenities were upgraded in 2019 to increase its capability and capacity to provide testing services for new viral threats using rapid and developed testing platforms. These strategic expansions are expected to impact the North American bioanalytical testing market positively.

Furthermore, it is anticipated that the market for bioanalytical testing services will expand significantly in the Asia Pacific region throughout the forecast period. The region’s bioanalytical testing service providers are increasing their investments, more businesses are relying on these services, and favorable business and regulatory reforms are all contributing to the growth of the global bioanalytical testing services market in the Asia Pacific market. Delivery centers in Manila, China, and India typically support outsourcing services in this region. China, in particular, is gaining traction as a delivery location for onshore and nearshore Japanese clients.

What is the regulatory landscape for the bioanalytical testing services market?

The need for bioanalytical testing services is expanding among the pharmaceutical and biotechnology sectors to support regulatory compliance and drug development. The regulatory body gets involved in the procedure at some point, typically during the pre-clinical stage, to supervise, manage, and ultimately approve the drug. The R&D landscape has started to change recently due to pharmaceutical research and development advancements. Many pharmaceutical companies outsource significant portions of their research and development (R&D) to clinical research organizations, also referred to as contract research organizations, to reduce costs. Pharmaceutical bioanalytical testing services are increasingly being outsourced owing to the increasingly strict global regulatory standards and the complexity of new drug development.

What are the major players planning for the future of the bioanalytical testing services market?

Companies are increasing their market share by offering various services and solutions in response to the growing trend of outsourcing laboratory testing services. Major players also focus on various strategies, including mergers, acquisitions, and other developments. For example, in August 2021, Eurofins Scientific agreed to acquire GeneTech Inc, a leading Japanese player in genetic analysis, from Noritsu Koki Co. Ltd to expand Eurofins’ testing portfolio in Japan. Likewise, in November 2021, Labcorp opened a new bioanalytical lab infrastructure in Singapore, expanding its central laboratory services and helping to enhance the capabilities of Singapore’s medical and biological ecosystem.

Segmentation of Global Bioanalytical Testing Services Market-

Global Bioanalytical Testing Services Market – By Type

• Cell-based Assays
• Bacterial cell-based assays
• Viral cell-based assays
• Virology Testing
• In Vitro Virology Testing
• In Vivo Virology Testing
• Species-specific Viral PCR Assays
• Method Development, Optimization, and Validation
• Serology, Immunogenicity, and Neutralizing Antibodies
• Biomarker Testing
• Pharmacokinetic Testing
• Other Services

Global Bioanalytical Testing Services Market – By Application

• Oncology
• Neurology
• Infectious Diseases
• Gastroenterology
• Cardiology
• Other Application

Global Bioanalytical Testing Services Market – By End User

• Pharmaceutical & Biopharmaceutical Companies
• Contact Development & Manufacturing Organizations
• Contact Research Organizations

Global Bioanalytical Testing Services Market – By Region

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Spain
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • South-east Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC Countries
  • South Africa
  • Rest of the Middle East and Africa

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Approach Adopted
1.3.4.1. Top-Down Approach
1.3.4.2. Bottom-Up Approach
1.3.5. Assumptions
1.3.6. Market Introduction
1.3.7. Market Research Scope

2. Executive Summary
2.1. Market Snapshot: Global Bioanalytical Testing Services Market
2.2. Global Bioanalytical Testing Services Market, By Type
2.3. Global Bioanalytical Testing Services Market, By End User
2.4. Global Bioanalytical Testing Services Market, By Application
2.5. Global Bioanalytical Testing Services Market, By Region

3. Market Dynamics & Factors Analysis

3.1. Introduction
3.1.1. Global Bioanalytical Testing Services Market Value, 2016-2028, (US$ Bn)
3.1.2. Y-o-Y Growth Trend Analysis
3.2. Market Dynamics
3.2.1. Market Drivers
3.2.2. Market Restraints
3.2.3. Market Opportunities
3.2.4. Major Industry Challenges
3.3. Growth and Development Patterns
3.4. Investment Feasibility Analysis
3.5. Market Opportunity Analysis
3.5.1. Type
3.5.2. End User
3.5.3. Application
3.5.4. Geography

4. Premium Insights
4.1. STAR (Situation, Task, Action, Results) Analysis
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of Buyers/Consumers
4.2.3. Bargaining Power of Suppliers
4.2.4. Threat of Substitute Types
4.2.5. Intensity of Competitive Rivalry
4.3. Key Market Trends
4.3.1. Demand Side Trends
4.3.2. Supply Side Trends
4.4. Value Chain Analysis
4.5. Technology Analysis
4.6. Analysis and Recommendations
4.7. Marketing Strategy Analysis
4.7.1. Direct Marketing
4.7.2. Indirect Marketing
4.7.3. Marketing Channel Development Trend

5. Market Positioning of Key Players, 2021
5.1. Company Market Share of Key Players, 2021
5.2. Competitive Benchmarking
5.3. Market Positioning of Key Vendors
5.4. Geographical Presence Analysis
5.5. Major Strategies Adopted by Key Players
5.5.1. Key Strategies Analysis
5.5.2. Mergers and Acquisitions
5.5.3. Partnerships
5.5.4. Product Launch
5.5.5. Geographical Expansion
5.5.6. Others

6. COVID-19 Impact Analysis
6.1. Global Bioanalytical Testing Services Market Pre Vs Post COVID-19, 2019 – 2028
6.2. Impact on Import & Export
6.3. Impact on Demand & Supply

7. Global Bioanalytical Testing Services Market
7.1. Global Bioanalytical Testing Services Market, by Type, 2016-2028(US$ Bn)
7.1.1. Overview
7.1.2. Global Bioanalytical Testing Services Market, By Type, 2021 vs 2028 (in%)
7.1.3. Global Bioanalytical Testing Services Market, By Cell-based Assays, 2016-2028 (US$ Bn)
7.1.4. Global Bioanalytical Testing Services Market, By Bacterial cell-based assays, 2016-2028 (US$ Bn)
7.1.5. Global Bioanalytical Testing Services Market, By Viral cell-based assays, 2016-2028 (US$ Bn)
7.1.6. Global Bioanalytical Testing Services Market, By In Vitro Virology Testing, 2016-2028 (US$ Bn)
7.1.7. Global Bioanalytical Testing Services Market, By In Vivo Virology Testing, 2016-2028 (US$ Bn)
7.1.8. Global Bioanalytical Testing Services Market, By Species-specific Viral PCR Assays, 2016-2028 (US$ Bn)
7.1.9. Global Bioanalytical Testing Services Market, By Method Development, Optimization, and Validation, 2016-2028 (US$ Bn)
7.1.10. Global Bioanalytical Testing Services Market, By Serology, Immunogenicity, and Neutralizing Antibodies, 2016-2028 (US$ Bn)
7.1.11. Global Bioanalytical Testing Services Market, By Biomarker Testing, 2016-2028 (US$ Bn)
7.1.12. Global Bioanalytical Testing Services Market, By Pharmacokinetic Testing, 2016-2028 (US$ Bn)
7.1.13. Global Bioanalytical Testing Services Market, By Other Services, 2016-2028 (US$ Bn)
7.1.14. Global Bioanalytical Testing Services Market, By Virology Testing, 2016-2028 (US$ Bn)
7.2. Global Bioanalytical Testing Services Market, by End User, 2016-2028(US$ Bn)
7.2.1. Overview
7.2.2. Global Bioanalytical Testing Services Market, By End User, 2021 vs 2028 (in%)
7.2.3. Global Bioanalytical Testing Services Market, By Pharmaceutical & Biopharmaceutical Companies, 2016-2028 (US$ Bn)
7.2.4. Global Bioanalytical Testing Services Market, By Contact Development & Manufacturing Organizations, 2016-2028 (US$ Bn)
7.2.5. Global Bioanalytical Testing Services Market, By Contact Research Organizations, 2016-2028 (US$ Bn)
7.3. Global Bioanalytical Testing Services Market, by Application, 2016-2028(US$ Bn)
7.3.1. Overview
7.3.2. Global Bioanalytical Testing Services Market, By Application, 2021 vs 2028 (in%)
7.3.3. Global Bioanalytical Testing Services Market, By Oncology, 2016-2028 (US$ Bn)
7.3.4. Global Bioanalytical Testing Services Market, By Neurology, 2016-2028 (US$ Bn)
7.3.5. Global Bioanalytical Testing Services Market, By Infectious Diseases, 2016-2028 (US$ Bn)
7.3.6. Global Bioanalytical Testing Services Market, By Gastroenterology, 2016-2028 (US$ Bn)
7.3.7. Global Bioanalytical Testing Services Market, By Cardiology, 2016-2028 (US$ Bn)

8. North America Bioanalytical Testing Services Market Analysis
8.1. North America Bioanalytical Testing Services Market, by Type, 2016-2028(US$ Bn)
8.1.1. Overview
8.1.2. SRC Analysis
8.2. North America Bioanalytical Testing Services Market, by End User, 2016-2028(US$ Bn)
8.2.1. Overview
8.2.2. SRC Analysis
8.3. North America Bioanalytical Testing Services Market, by Application, 2016-2028(US$ Bn)
8.3.1. Overview
8.3.2. SRC Analysis
8.4. North America Bioanalytical Testing Services Market, by Country, 2016-2028 (US$ Bn)
8.4.1. U.S.
8.4.1.1. U.S. Bioanalytical Testing Services Market Estimates and Forecast, 2016-2028 (US$ Bn)
8.4.1.2. U.S. Bioanalytical Testing Services, By Type, 2016-2028 (US$ Bn)
8.4.1.3. U.S. Bioanalytical Testing Services, By End User, 2016-2028 (US$ Bn)
8.4.1.4. U.S. Bioanalytical Testing Services, By Application, 2016-2028 (US$ Bn)
8.4.2. Canada
8.4.2.1. Canada Bioanalytical Testing Services Market Estimates and Forecast, 2016-2028 (US$ Bn)
8.4.2.2. Canada Bioanalytical Testing Services, By Type, 2016-2028 (US$ Bn)
8.4.2.3. Canada Bioanalytical Testing Services, By End User, 2016-2028 (US$ Bn)
8.4.2.4. Canada Bioanalytical Testing Services, By Application, 2016-2028 (US$ Bn)

9. Europe Bioanalytical Testing Services Market Analysis
9.1. Europe Bioanalytical Testing Services Market, by Type, 2016-2028(US$ Bn)
9.1.1. Overview
9.1.2. SRC Analysis
9.2. Europe Bioanalytical Testing Services Market, by End User, 2016-2028(US$ Bn)
9.2.1. Overview
9.2.2. SRC Analysis
9.3. Europe Bioanalytical Testing Services Market, by Application, 2016-2028(US$ Bn)
9.3.1. Overview
9.3.2. SRC Analysis
9.4. Europe Bioanalytical Testing Services Market, by Country, 2016-2028 (US$ Bn)
9.4.1. Germany
9.4.1.1. Germany Bioanalytical Testing Services Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.4.1.2. Germany Bioanalytical Testing Services, By Type, 2016-2028 (US$ Bn)
9.4.1.3. Germany Bioanalytical Testing Services, By End User, 2016-2028 (US$ Bn)
9.4.1.4. Germany Bioanalytical Testing Services, By Application, 2016-2028 (US$ Bn)
9.4.2. France
9.4.2.1. France Bioanalytical Testing Services Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.4.2.2. France Bioanalytical Testing Services, By Type, 2016-2028 (US$ Bn)
9.4.2.3. France Bioanalytical Testing Services, By End User, 2016-2028 (US$ Bn)
9.4.2.4. France Bioanalytical Testing Services, By Application, 2016-2028 (US$ Bn)
9.4.3. UK
9.4.3.1. UK Bioanalytical Testing Services Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.4.3.2. UK Bioanalytical Testing Services, By Type, 2016-2028 (US$ Bn)
9.4.3.3. UK Bioanalytical Testing Services, By End User, 2016-2028 (US$ Bn)
9.4.3.4. UK Bioanalytical Testing Services, By Application, 2016-2028 (US$ Bn)
9.4.4. Italy
9.4.4.1. Italy Bioanalytical Testing Services Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.4.4.2. Italy Bioanalytical Testing Services, By Type, 2016-2028 (US$ Bn)
9.4.4.3. Italy Bioanalytical Testing Services, By End User, 2016-2028 (US$ Bn)
9.4.4.4. Italy Bioanalytical Testing Services, By Application, 2016-2028 (US$ Bn)
9.4.5. Spain
9.4.5.1. Spain Bioanalytical Testing Services Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.4.5.2. Spain Bioanalytical Testing Services, By Type, 2016-2028 (US$ Bn)
9.4.5.3. Spain Bioanalytical Testing Services, By End User, 2016-2028 (US$ Bn)
9.4.5.4. Spain Bioanalytical Testing Services, By Application, 2016-2028 (US$ Bn)
9.4.6. Rest of Europe
9.4.6.1. Rest of Europe Bioanalytical Testing Services Market Estimates and Forecast, 2016-2028 (US$ Bn)
9.4.6.2. Rest of Europe Bioanalytical Testing Services, By Type, 2016-2028 (US$ Bn)
9.4.6.3. Rest of Europe Bioanalytical Testing Services, By End User, 2016-2028 (US$ Bn)
9.4.6.4. Rest of Europe Bioanalytical Testing Services, By Application, 2016-2028 (US$ Bn)

10. Asia Pacific Bioanalytical Testing Services Market Analysis
10.1. Asia Pacific Bioanalytical Testing Services Market, by Type, 2016-2028(US$ Bn)
10.1.1. Overview
10.1.2. SRC Analysis
10.2. Asia Pacific Bioanalytical Testing Services Market, by End User, 2016-2028(US$ Bn)
10.2.1. Overview
10.2.2. SRC Analysis
10.3. Asia Pacific Bioanalytical Testing Services Market, by Application, 2016-2028(US$ Bn)
10.3.1. Overview
10.3.2. SRC Analysis
10.4. Asia Pacific Bioanalytical Testing Services Market, by Country, 2016-2028 (US$ Bn)
10.4.1. China
10.4.1.1. China Bioanalytical Testing Services Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.4.1.2. China Bioanalytical Testing Services, By Type, 2016-2028 (US$ Bn)
10.4.1.3. China Bioanalytical Testing Services, By End User, 2016-2028 (US$ Bn)
10.4.1.4. China Bioanalytical Testing Services, By Application, 2016-2028 (US$ Bn)
10.4.2. Japan
10.4.2.1. Japan Bioanalytical Testing Services Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.4.2.2. Japan Bioanalytical Testing Services, By Type, 2016-2028 (US$ Bn)
10.4.2.3. Japan Bioanalytical Testing Services, By End User, 2016-2028 (US$ Bn)
10.4.2.4. Japan Bioanalytical Testing Services, By Application, 2016-2028 (US$ Bn)
10.4.3. India
10.4.3.1. India Bioanalytical Testing Services Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.4.3.2. India Bioanalytical Testing Services, By Type, 2016-2028 (US$ Bn)
10.4.3.3. India Bioanalytical Testing Services, By End User, 2016-2028 (US$ Bn)
10.4.3.4. India Bioanalytical Testing Services, By Application, 2016-2028 (US$ Bn)
10.4.4. South Korea
10.4.4.1. South Korea Bioanalytical Testing Services Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.4.4.2. South Korea Bioanalytical Testing Services, By Type, 2016-2028 (US$ Bn)
10.4.4.3. South Korea Bioanalytical Testing Services, By End User, 2016-2028 (US$ Bn)
10.4.4.4. South Korea Bioanalytical Testing Services, By Application, 2016-2028 (US$ Bn)
10.4.5. South-East Asia
10.4.5.1. South-East Asia Bioanalytical Testing Services Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.4.5.2. South-East Asia Bioanalytical Testing Services, By Type, 2016-2028 (US$ Bn)
10.4.5.3. South-East Asia Bioanalytical Testing Services, By End User, 2016-2028 (US$ Bn)
10.4.5.4. South-East Asia Bioanalytical Testing Services, By Application, 2016-2028 (US$ Bn)
10.4.6. Rest of Asia Pacific
10.4.6.1. Rest of Asia Pacific Bioanalytical Testing Services Market Estimates and Forecast, 2016-2028 (US$ Bn)
10.4.6.2. Rest of Asia Pacific Bioanalytical Testing Services, By Type, 2016-2028 (US$ Bn)
10.4.6.3. Rest of Asia Pacific Bioanalytical Testing Services, By End User, 2016-2028 (US$ Bn)
10.4.6.4. Rest of Asia Pacific Bioanalytical Testing Services, By Application, 2016-2028 (US$ Bn)

11. Latin America Bioanalytical Testing Services Market Analysis
11.1. Latin America Bioanalytical Testing Services Market, by Type, 2016-2028(US$ Bn)
11.1.1. Overview
11.1.2. SRC Analysis
11.2. Latin America Bioanalytical Testing Services Market, by End User, 2016-2028(US$ Bn)
11.2.1. Overview
11.2.2. SRC Analysis
11.3. Latin America Bioanalytical Testing Services Market, by Application, 2016-2028(US$ Bn)
11.3.1. Overview
11.3.2. SRC Analysis
11.4. Latin America Bioanalytical Testing Services Market, by Country, 2016-2028 (US$ Bn)
11.4.1. Brazil
11.4.1.1. Brazil Bioanalytical Testing Services Market Estimates and Forecast, 2016-2028 (US$ Bn)
11.4.1.2. Brazil Bioanalytical Testing Services, By Type, 2016-2028 (US$ Bn)
11.4.1.3. Brazil Bioanalytical Testing Services, By End User, 2016-2028 (US$ Bn)
11.4.1.4. Brazil Bioanalytical Testing Services, By Application, 2016-2028 (US$ Bn)
11.4.2. Mexico
11.4.2.1. Mexico Bioanalytical Testing Services Market Estimates and Forecast, 2016-2028 (US$ Bn)
11.4.2.2. Mexico Bioanalytical Testing Services, By Type, 2016-2028 (US$ Bn)
11.4.2.3. Mexico Bioanalytical Testing Services, By End User, 2016-2028 (US$ Bn)
11.4.2.4. Mexico Bioanalytical Testing Services, By Application, 2016-2028 (US$ Bn)
11.4.3. Rest of Latin America
11.4.3.1. Rest of Latin America Bioanalytical Testing Services Market Estimates and Forecast, 2016-2028 (US$ Bn)
11.4.3.2. Rest of Latin America Bioanalytical Testing Services, By Type, 2016-2028 (US$ Bn)
11.4.3.3. Rest of Latin America Bioanalytical Testing Services, By End User, 2016-2028 (US$ Bn)
11.4.3.4. Rest of Latin America Bioanalytical Testing Services, By Application, 2016-2028 (US$ Bn)

12. Middle East and Africa Bioanalytical Testing Services Market Analysis
12.1. Middle East and Africa Bioanalytical Testing Services Market, by Type, 2016-2028(US$ Bn)
12.1.1. Overview
12.1.2. SRC Analysis
12.2. Middle East and Africa Bioanalytical Testing Services Market, by End User, 2016-2028(US$ Bn)
12.2.1. Overview
12.2.2. SRC Analysis
12.3. Middle East and Africa Bioanalytical Testing Services Market, by Application, 2016-2028(US$ Bn)
12.3.1. Overview
12.3.2. SRC Analysis
12.4. Middle East and Africa Bioanalytical Testing Services Market, by Country, 2016-2028 (US$ Bn)
12.4.1. GCC Countries
12.4.1.1. GCC Countries il Bioanalytical Testing Services Market Estimates and Forecast, 2016-2028 (US$ Bn)
12.4.1.2. GCC Countries Bioanalytical Testing Services, By Type, 2016-2028 (US$ Bn)
12.4.1.3. GCC Countries Bioanalytical Testing Services, By End User, 2016-2028 (US$ Bn)
12.4.1.4. GCC Countries Bioanalytical Testing Services, By Application, 2016-2028 (US$ Bn)
12.4.2. South Africa
12.4.2.1. South Africa Bioanalytical Testing Services Market Estimates and Forecast, 2016-2028 (US$ Bn)
12.4.2.2. South Africa Bioanalytical Testing Services, By Type, 2016-2028 (US$ Bn)
12.4.2.3. South Africa Bioanalytical Testing Services, By End User, 2016-2028 (US$ Bn)
12.4.2.4. South Africa Bioanalytical Testing Services, By Application, 2016-2028 (US$ Bn)
12.4.3. Rest of Middle East and Africa
12.4.3.1. Rest of Middle East and Africa Bioanalytical Testing Services Market Estimates and Forecast, 2016-2028 (US$ Bn)
12.4.3.2. Rest of Middle East and Africa Bioanalytical Testing Services, By Type, 2016-2028 (US$ Bn)
12.4.3.3. Rest of Middle East and Africa Bioanalytical Testing Services, By End User, 2016-2028 (US$ Bn)
12.4.3.4. Rest of Middle East and Africa Bioanalytical Testing Services, By Application, 2016-2028 (US$ Bn)

13. Company Profiles
13.1. PPD
13.1.1. Company Overview
13.1.2. Products/Services Portfolio
13.1.3. Geographical Presence
13.1.4. Financial Summary
13.1.4.1. Market Revenue and Net Profit (2019-2021)
13.1.4.2. Business Segment Revenue Analysis
13.1.4.3. Geographical Revenue Analysis
13.2. Icon Plc
13.3. Covance Inc
13.4. LabCorp
13.5. Charles River Laboratories International Inc
13.6. Syneos Health
13.7. SGS SA
13.8. Toxikon Inc
13.9. Intertek Group
13.10. Pace Analytical Services LLC
13.11. Others

List of Figures
FIG. 1 Global Bioanalytical Testing Services Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global Bioanalytical Testing Services Market Segmentation
FIG. 4 Global Bioanalytical Testing Services Market, by Type, 2021 (US$ Bn)
FIG. 5 Global Bioanalytical Testing Services Market, by End User, 2021 (US$ Bn)
FIG. 6 Global Bioanalytical Testing Services Market, by Application, 2021 (US$ Bn)
FIG. 7 Global Bioanalytical Testing Services Market, by Geography, 2021 (US$ Bn)
FIG. 8 Attractive Investment Proposition, by Type, 2021
FIG. 9 Attractive Investment Proposition, by End User, 2021
FIG. 10 Attractive Investment Proposition, by Application, 2021
FIG. 11 Attractive Investment Proposition, by Geography, 2021
FIG. 12 Global Market Share Analysis of Key Bioanalytical Testing Services Market Manufacturers, 2021
FIG. 13 Global Market Positioning of Key Bioanalytical Testing Services Market Manufacturers, 2021
FIG. 14 Global Bioanalytical Testing Services Market Value Contribution, By Type, 2021 & 2028 (Value %)
FIG. 15 Global Bioanalytical Testing Services Market, by Cell-based Assays, Value, 2016-2028 (US$ Bn)
FIG. 16 Global Bioanalytical Testing Services Market, by Bacterial cell-based assays, Value, 2016-2028 (US$ Bn)
FIG. 17 Global Bioanalytical Testing Services Market, by Viral cell-based assays, Value, 2016-2028 (US$ Bn)
FIG. 18 Global Bioanalytical Testing Services Market, by Virology Testing, Value, 2016-2028 (US$ Bn)
FIG. 19 Global Bioanalytical Testing Services Market, by In Vitro Virology Testing, Value, 2016-2028 (US$ Bn)
FIG. 20 Global Bioanalytical Testing Services Market, by In Vivo Virology Testing, Value, 2016-2028 (US$ Bn)
FIG. 21 Global Bioanalytical Testing Services Market, by Species-specific Viral PCR Assays, Value, 2016-2028 (US$ Bn)
FIG. 22 Global Bioanalytical Testing Services Market, by Method Development, Optimization, and Validation, Value, 2016-2028 (US$ Bn)
FIG. 23 Global Bioanalytical Testing Services Market, by Serology, Immunogenicity, and Neutralizing Antibodies, Value, 2016-2028 (US$ Bn)
FIG. 24 Global Bioanalytical Testing Services Market, by Biomarker Testing, Value, 2016-2028 (US$ Bn)
FIG. 25 Global Bioanalytical Testing Services Market, by Pharmacokinetic Testing, Value, 2016-2028 (US$ Bn)
FIG. 26 Global Bioanalytical Testing Services Market, by Other Services, Value, 2016-2028 (US$ Bn)
FIG. 27 Global Bioanalytical Testing Services Market Value Contribution, By End User, 2021 & 2028 (Value %)
FIG. 28 Global Bioanalytical Testing Services Market, by Pharmaceutical & Biopharmaceutical Companies, Value, 2016-2028 (US$ Bn)
FIG. 29 Global Bioanalytical Testing Services Market, by Contact Development & Manufacturing Organizations, Value, 2016-2028 (US$ Bn)
FIG. 30 Global Bioanalytical Testing Services Market, by Contact Research Organizations, Value, 2016-2028 (US$ Bn)
FIG. 31 Global Bioanalytical Testing Services Market Value Contribution, By Application, 2021 & 2028 (Value %)
FIG. 32 Global Bioanalytical Testing Services Market, by Oncology, Value, 2016-2028 (US$ Bn)
FIG. 33 Global Bioanalytical Testing Services Market, by Neurology, Value, 2016-2028 (US$ Bn)
FIG. 34 Global Bioanalytical Testing Services Market, by Infectious Diseases, Value, 2016-2028 (US$ Bn)
FIG. 35 Global Bioanalytical Testing Services Market, by Gastroenterology, Value, 2016-2028 (US$ Bn)
FIG. 36 Global Bioanalytical Testing Services Market, by Cardiology, Value, 2016-2028 (US$ Bn)
FIG. 37 Global Bioanalytical Testing Services Market, by Other Application, Value, 2016-2028 (US$ Bn)
FIG. 38 U.S. Bioanalytical Testing Services Market, 2016-2028 (US$ Bn)
FIG. 39 Canada Bioanalytical Testing Services Market, 2016-2028 (US$ Bn)
FIG. 40 Germany Bioanalytical Testing Services Market, 2016-2028 (US$ Bn)
FIG. 41 France Bioanalytical Testing Services Market, 2016-2028 (US$ Bn)
FIG. 42 U.K. Bioanalytical Testing Services Market, 2016-2028 (US$ Bn)
FIG. 43 Italy Bioanalytical Testing Services Market, 2016-2028 (US$ Bn)
FIG. 44 Spain Bioanalytical Testing Services Market, 2016-2028 (US$ Bn)
FIG. 45 Rest of Europe Bioanalytical Testing Services Market, 2016-2028 (US$ Bn)
FIG. 46 China Bioanalytical Testing Services Market, 2016-2028 (US$ Bn)
FIG. 47 Japan Bioanalytical Testing Services Market, 2016-2028 (US$ Bn)
FIG. 48 India Bioanalytical Testing Services Market, 2016-2028 (US$ Bn)
FIG. 49 South Korea Bioanalytical Testing Services Market, 2016-2028 (US$ Bn)
FIG. 50 Southeast Asia Bioanalytical Testing Services Market, 2016-2028 (US$ Bn)
FIG. 51 Rest of Asia Pacific Bioanalytical Testing Services Market, 2016-2028 (US$ Bn)
FIG. 52 Latin America Bioanalytical Testing Services Market, 2016-2028 (US$ Bn)
FIG. 53 Brazil Bioanalytical Testing Services Market, 2016-2028 (US$ Bn)
FIG. 54 Mexico Bioanalytical Testing Services Market, 2016-2028 (US$ Bn)
FIG. 55 Rest of Latin America Bioanalytical Testing Services Market, 2016-2028 (US$ Bn)
FIG. 56 Middle East & Africa Bioanalytical Testing Services Market, 2016-2028 (US$ Bn)
FIG. 57 GCC Countries Bioanalytical Testing Services Market, 2016-2028 (US$ Bn)
FIG. 58 South Africa Bioanalytical Testing Services Market, 2016-2028 (US$ Bn)
FIG. 59 Rest of Middle East and Africa Bioanalytical Testing Services Market, 2016-2028 (US$ Bn)

List of Tables
TABLE 1 Market Snapshot: Global Bioanalytical Testing Services Market
TABLE 2 Global Bioanalytical Testing Services Market, by Competitive Benchmarking, 2021
TABLE 3 Global Bioanalytical Testing Services Market, by Geographical Presence Analysis, 2021
TABLE 4 Global Bioanalytical Testing Services Market, by Key Strategies Analysis, 2021
TABLE 5 Global Bioanalytical Testing Services Market, by Type, 2016-2028 (US$ Bn)
TABLE 6 Global Bioanalytical Testing Services Market, by End User, 2016-2028 (US$ Bn)
TABLE 7 Global Bioanalytical Testing Services Market, by Application, 2016-2028 (US$ Bn)
TABLE 8 Global Bioanalytical Testing Services Market, by Geography, 2016-2028 (US$ Bn)
TABLE 9 North America Bioanalytical Testing Services Market, by Type, 2016-2028 (US$ Bn)
TABLE 10 North America Bioanalytical Testing Services Market, by End User, 2016-2028 (US$ Bn)
TABLE 11 North America Bioanalytical Testing Services Market, by Application, 2016-2028 (US$ Bn)
TABLE 12 North America Bioanalytical Testing Services Market, by Country, 2016-2028 (US$ Bn)
TABLE 13 US Bioanalytical Testing Services Market, by Type, 2016-2028 (US$ Bn)
TABLE 14 US Bioanalytical Testing Services Market, by End User, 2016-2028 (US$ Bn)
TABLE 15 US Bioanalytical Testing Services Market, by Application, 2016-2028 (US$ Bn)
TABLE 16 Canada Bioanalytical Testing Services Market, by Type, 2016-2028 (US$ Bn)
TABLE 17 Canada Bioanalytical Testing Services Market, by End User, 2016-2028 (US$ Bn)
TABLE 18 Canada Bioanalytical Testing Services Market, by Application, 2016-2028 (US$ Bn)
TABLE 19 Europe Bioanalytical Testing Services Market, by Type, 2016-2028 (US$ Bn)
TABLE 20 Europe Bioanalytical Testing Services Market, by End User, 2016-2028 (US$ Bn)
TABLE 21 Europe Bioanalytical Testing Services Market, by Application, 2016-2028 (US$ Bn)
TABLE 22 Europe Bioanalytical Testing Services Market, by Country, 2016-2028 (US$ Bn)
TABLE 23 Germany Bioanalytical Testing Services Market, by Type, 2016-2028 (US$ Bn)
TABLE 24 Germany Bioanalytical Testing Services Market, by End User, 2016-2028 (US$ Bn)
TABLE 25 Germany Bioanalytical Testing Services Market, by Application, 2016-2028 (US$ Bn)
TABLE 26 France Bioanalytical Testing Services Market, by Type, 2016-2028 (US$ Bn)
TABLE 27 France Bioanalytical Testing Services Market, by End User, 2016-2028 (US$ Bn)
TABLE 28 France Bioanalytical Testing Services Market, by Application, 2016-2028 (US$ Bn)
TABLE 29 UK Bioanalytical Testing Services Market, by Type, 2016-2028 (US$ Bn)
TABLE 30 UK Bioanalytical Testing Services Market, by End User, 2016-2028 (US$ Bn)
TABLE 31 UK Bioanalytical Testing Services Market, by Application, 2016-2028 (US$ Bn)
TABLE 32 Italy Bioanalytical Testing Services Market, by Type, 2016-2028 (US$ Bn)
TABLE 33 Italy Bioanalytical Testing Services Market, by End User, 2016-2028 (US$ Bn)
TABLE 34 Italy Bioanalytical Testing Services Market, by Application, 2016-2028 (US$ Bn)
TABLE 35 Spain Bioanalytical Testing Services Market, by Type, 2016-2028 (US$ Bn)
TABLE 36 Spain Bioanalytical Testing Services Market, by End User, 2016-2028 (US$ Bn)
TABLE 37 Spain Bioanalytical Testing Services Market, by Application, 2016-2028 (US$ Bn)
TABLE 38 Rest of Europe Bioanalytical Testing Services Market, by Type, 2016-2028 (US$ Bn)
TABLE 39 Rest of Europe Bioanalytical Testing Services Market, by End User, 2016-2028 (US$ Bn)
TABLE 40 Rest of Europe Bioanalytical Testing Services Market, by Application, 2016-2028 (US$ Bn)
TABLE 41 Asia Pacific Bioanalytical Testing Services Market, by Type, 2016-2028 (US$ Bn)
TABLE 42 Asia Pacific Bioanalytical Testing Services Market, by End User, 2016-2028 (US$ Bn)
TABLE 43 Asia Pacific Bioanalytical Testing Services Market, by Application, 2016-2028 (US$ Bn)
TABLE 44 Asia Pacific Bioanalytical Testing Services Market, by Country, 2016-2028 (US$ Bn)
TABLE 45 China Bioanalytical Testing Services Market, by Type, 2016-2028 (US$ Bn)
TABLE 46 China Bioanalytical Testing Services Market, by End User, 2016-2028 (US$ Bn)
TABLE 47 China Bioanalytical Testing Services Market, by Application, 2016-2028 (US$ Bn)
TABLE 48 Japan Bioanalytical Testing Services Market, by Type, 2016-2028 (US$ Bn)
TABLE 49 Japan Bioanalytical Testing Services Market, by End User, 2016-2028 (US$ Bn)
TABLE 50 Japan Bioanalytical Testing Services Market, by Application, 2016-2028 (US$ Bn)
TABLE 51 India Bioanalytical Testing Services Market, by Type, 2016-2028 (US$ Bn)
TABLE 52 India Bioanalytical Testing Services Market, by End User, 2016-2028 (US$ Bn)
TABLE 53 India Bioanalytical Testing Services Market, by Application, 2016-2028 (US$ Bn)
TABLE 54 South Korea Bioanalytical Testing Services Market, by Type, 2016-2028 (US$ Bn)
TABLE 55 South Korea Bioanalytical Testing Services Market, by End User, 2016-2028 (US$ Bn)
TABLE 56 South Korea Bioanalytical Testing Services Market, by Application, 2016-2028 (US$ Bn)
TABLE 57 South East Asia Bioanalytical Testing Services Market, by Type, 2016-2028 (US$ Bn)
TABLE 58 South East Asia Bioanalytical Testing Services Market, by End User, 2016-2028 (US$ Bn)
TABLE 59 South East Asia Bioanalytical Testing Services Market, by Application, 2016-2028 (US$ Bn)
TABLE 60 Rest of Asia Pacific Bioanalytical Testing Services Market, by Type, 2016-2028 (US$ Bn)
TABLE 61 Rest of Asia Pacific Bioanalytical Testing Services Market, by End User, 2016-2028 (US$ Bn)
TABLE 62 Rest of Asia Pacific Bioanalytical Testing Services Market, by Application, 2016-2028 (US$ Bn)
TABLE 63 Latin America Bioanalytical Testing Services Market, by Type, 2016-2028 (US$ Bn)
TABLE 64 Latin America Bioanalytical Testing Services Market, by End User, 2016-2028 (US$ Bn)
TABLE 65 Latin America Bioanalytical Testing Services Market, by Application, 2016-2028 (US$ Bn)
TABLE 66 Latin America Bioanalytical Testing Services Market, by Country, 2016-2028 (US$ Bn)
TABLE 67 Brazil Bioanalytical Testing Services Market, by Type, 2016-2028 (US$ Bn)
TABLE 68 Brazil Bioanalytical Testing Services Market, by End User, 2016-2028 (US$ Bn)
TABLE 69 Brazil Bioanalytical Testing Services Market, by Application, 2016-2028 (US$ Bn)
TABLE 70 Mexico Bioanalytical Testing Services Market, by Type, 2016-2028 (US$ Bn)
TABLE 71 Mexico Bioanalytical Testing Services Market, by End User, 2016-2028 (US$ Bn)
TABLE 72 Mexico Bioanalytical Testing Services Market, by Application, 2016-2028 (US$ Bn)
TABLE 73 Rest of Latin America Bioanalytical Testing Services Market, by Type, 2016-2028 (US$ Bn)
TABLE 74 Rest of Latin America Bioanalytical Testing Services Market, by End User, 2016-2028 (US$ Bn)
TABLE 75 Rest of Latin America Bioanalytical Testing Services Market, by Application, 2016-2028 (US$ Bn)
TABLE 76 Middle East and Africa Bioanalytical Testing Services Market, by Type, 2016-2028 (US$ Bn)
TABLE 77 Middle East and Africa Bioanalytical Testing Services Market, by End User, 2016-2028 (US$ Bn)
TABLE 78 Middle East and Africa Bioanalytical Testing Services Market, by Application, 2016-2028 (US$ Bn)
TABLE 79 Middle East and Africa Bioanalytical Testing Services Market, by Country, 2016-2028 (US$ Bn)
TABLE 80 GCC Countries Bioanalytical Testing Services Market, by Type, 2016-2028 (US$ Bn)
TABLE 81 GCC Countries Bioanalytical Testing Services Market, by End User, 2016-2028 (US$ Bn)
TABLE 82 GCC Countries Bioanalytical Testing Services Market, by Application, 2016-2028 (US$ Bn)
TABLE 83 South Africa Bioanalytical Testing Services Market, by Type, 2016-2028 (US$ Bn)
TABLE 84 South Africa Bioanalytical Testing Services Market, by End User, 2016-2028 (US$ Bn)
TABLE 85 South Africa Bioanalytical Testing Services Market, by Application, 2016-2028 (US$ Bn)
TABLE 86 Rest of Middle East and Africa Bioanalytical Testing Services Market, by Type, 2016-2028 (US$ Bn)
TABLE 87 Rest of Middle East and Africa Bioanalytical Testing Services Market, by End User, 2016-2028 (US$ Bn)
TABLE 88 Rest of Middle East and Africa Bioanalytical Testing Services Market, by Application, 2016-2028 (US$ Bn)